QA: Epizyme Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001571498_2019_Epizyme_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001571498, Epizyme Inc

  xvar xval
0 AssetsCurrent 272,535,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,057,000
3 remainder_Assets 909,000
4 LiabilitiesCurrent 37,833,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 47,226,675
9 ResearchAndDevelopmentExpense 104,861,501
10 remainder_Expenses -334,288
11 remainder_Revenues 21,700,000
12 remainder_NetIncome 7,494,498
13 remainder_ComprehensiveNetIncome 26,237
  yvar yval
0 Assets 275,501,000
1 Liabilities 37,833,000
2 Expenses 151,753,888
3 Revenues 21,700,000
4 StockholdersEquity 237,668,000
5 NetIncome -122,559,390
6 ComprehensiveNetIncome -122,546,272
7 BaseVar 247,154,312
8 EconomicCapitalRatiobeforeLimitedLiability 2.52
9 EconomicCapitalRatio 3.37

Edgar->Model Mapping

Feature Distribution

Change over Time